Page 31 - Admired companies 2020
P. 31
projects from around the country. continuously evolve ourselves in line with market
changes and voices of customers.
What led to the inception of the company?
What are your company’s future aspirations?
CMIC, Inc. originated from CMIC Group, which the What strategies are you undertaking to achieve
very first and largest Contract Research Organization those goals?
(CRO) and also the top bioanalysis lab in Japan. It
was established as a strategic cornerstone for CMIC By further expanding from the current
Group’s North America growth. “Pharmaceutical Value Creator” (PVC) business
model, we have an aspiration to become a “Personal
Describe your company and its cutting-edge solutions Healthcare Value Creator” (PHVC) to contribute
which address all the needs of your customers? for and to address to the up-coming personalized
We have been the leading bioanalysis CRO in medicine and individual patient quality of life.
oligonucleotide therapeutics (Oligo) for several About the leader With 30+ years of experience
years now. Even before Oligo, we have 30+ years of across biotechnology, pharmaceutical, life sciences
experience in conventional small molecule and are industry, and medical device areas, Mike Suga has
also significantly expanding our capabilities in large been assuming CMIC. Inc.’s President role since
molecule and biomarker. 2015. He earned bachelor and master’s degrees
Could you throw some light on your mission and in agricultural biosciences from the University of
vision statement? Tokyo. Prior joining CMIC, he was the Deputy
General Manager of GE Healthcare’s CT/MRI
CMIC has the vision to provide a solution service contrast media in vivo diagnostics and PET/SPECT
called “Pharmaceutical Value Creator” (PVC) that radiopharmaceuticals division in Japan and was
encompass an entire value-chain of pharmaceutical responsible for establishing a new pharmaceutical
companies, not only on CRO, but also on operation reporting into GE Healthcare’s U.K
manufacturing, sales, and marketing service solutions. Headquarters.
How do your services differ from the other He and other leadership team members, with 15 to
companies’ offerings? 25+ years of the industry experience, are helping the
company to grow and address the bioanalysis CRO
We are the leading bioanalysis CRO in oligonucleotide needs from mid-to-small/bio venture clients who
therapeutics (Oligo) as well as very flexible and agile were not well served by other large-scale CROs.
with quick turn-around time, which is not possible by He together with the current leadership team also
large CROs. competed strategic facility investment in 2017,
What marketing activities do you implement to leveraged by CMIC’s new U.S. client base expansion
reach out to your potential customers? after business integration.
CMIC, Inc. together with the rest of CMIC Group Mike is based in Chicago, while he also serves as
has, several scientific publications and whitepapers Senior Vice President of CMIC HOLDINGS Co.,
and several webinars either already implemented or Ltd., reporting directly to CMIC Group’s Tokyo
planned. Headquarters. He started his 30-year’s professional
career as tissue culture and genomics scientists at
How do you cope up with the volatile technological JT genetic engineering lab and later spent 5 years in
changes in the market to make your solutions New York and San Francisco as JT’s recombinant
resourceful? DNA business development manager. “As CMIC,
Inc., we will accelerate our growth of services in
CMIC’s “CREED” as corporate philosophy is North America and most importantly better aligns
consisting of Wellbeing, Challenge, Change and with our overall vision to bring value with each client
Communication (W&3Cs). We apply these items to interaction,” Says Mike Suga.
January 2020 31
